In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.
We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.
Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
Read through case studies where we openly examine and analyse all our actions and decision-making processes during humanitarian emergencies that have led us to speak out.
This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.
This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.
This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.
SAMU provides strategic, clinical and implementation support to various MSF projects with medical activities related to HIV and TB. This medical unit is based in Cape Town, South Africa.
BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
Access to healthcare remains limited for people living along the frontline of the conflict in eastern Ukraine, which started back in 2014.
We continue to run mobile clinics along the frontline, and increased psychological and medical support to people living in the areas controlled by the Ukrainian government, including those who had been displaced.
Our psychologists work in the southern part of the conflict zone, providing consultations for patients suffering from acute or chronic stress.
We also ensure continuity of care for people suffering from chronic diseases such as diabetes and hypertension, as the conflict has interrupted their access to drugs and medical services.
0
4,770
outpatient consultations
0
2,660
individual mental health consultations
0
490
people treated for hepatitis C
video
Curing hepatitis C in Ukraine with effective drugs and patient support
Curing hepatitis C in Ukraine with effective drugs and patient support
At least five per cent of the population - or two million people - in Ukraine are infected with hepatitis C, according to estimates from World Health Organization.
If left untreated, hepatitis C can lead to liver fibrosis, cirrhosis, liver cancer and even death. Fortunately, hepatitis C is preventable and curable.
Until recently, treatment for hepatitis C was painfully long and costly and came with toxic side effects. But newer direct-acting antivirals (DAAs) have revolutionised hepatitis C care, making treatment faster and more effective while significantly reducing side effects. Drug prices however remain prodigiously high and poor access to diagnosis severely limits scaling up the treatment.
In 2017, MSF opened a project in southern Ukraine that offers innovative hepatitis C treatment using advanced drugs that can cure hepatitis C in as little as 12 weeks.
Ukraine
MSF concludes medical humanitarian activities in Bakhmut
Press Release29 Jul 2016
Ukraine
We are lost here and very scared
Project Update5 Jul 2016
Attacks on medical care
MSF President to UN Security Council: "Stop these attacks"
Statement3 May 2016
Ukraine
Termination of MSF support to MDR-TB programme in the penitentiary system after accreditation was cancelled on 19 October
Project Update13 Nov 2015
Ukraine
MSF strongly refutes false allegations levelled in the media by the Humanitarian Committee of the Donetsk People’s Republic
Statement26 Oct 2015
Ukraine
MSF refused permission to work in Lugansk, leaving vulnerable people deprived of essential healthcare and medicines
Statement25 Sep 2015
1999
1999
Year MSF first worked in the country
Related topics
Medical Activities
Tuberculosis
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.7 million people in 2016, TB is the world’s deadliest infectious disease (WHO).
Crisis Settings
Access to medicines
Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines.
Crisis Settings
War and conflict
Around one-third of our humanitarian and medical assistance is for populations caught in armed conflict.
Medical Activities
Mental health
Where we work, we may see people with a mental illness or confronting distressing situations, such as violence, loss or displacement. Mental health support can be crucial to help people cope.
